Kanoria Chemicals Q1FY27: Profit jumps to ₹26.36 cr

What changed in the June 2026 quarter

Kanoria Chemicals & Industries reported a sharp turnaround in the quarter ended June 30, 2026 (Q1FY27), moving from loss to profit on a steep rise in revenue. The company reported consolidated net profit of ₹26.36 crore, compared with a consolidated net loss of ₹13.78 crore in Q1FY26. Revenue from operations also rose strongly year-on-year. The unaudited standalone and consolidated financial results were approved by the Board of Directors on August 11, 2026.

Market participants tracked the update closely as the quarter marked a decisive improvement versus the year-ago period. The disclosures also came alongside other corporate actions and calendar events, including an upcoming AGM and a trading window closure for designated persons.

Consolidated results: revenue up, EBITDA higher

In the company’s consolidated numbers for Q1FY27, revenue from operations was reported at ₹460.37 crore (₹46,037 lakh), compared with ₹201.38 crore (₹20,138 lakh) in Q1FY26. Consolidated EBITDA rose to ₹51.76 crore (₹5,176 lakh) from ₹18.68 crore (₹1,868 lakh), as per the table shared in the results summary. Net profit for the quarter stood at ₹26.36 crore (₹2,636 lakh), compared with a loss of ₹13.78 crore (₹1,378 lakh) in the year-ago quarter.

Earnings per share (basic and diluted) were reported at ₹6.03 in Q1FY27, versus ₹(1.79) in Q1FY26. The company’s reported change was described as a turnaround, given the swing from negative to positive profitability. Separately, a market data summary also stated that sales rose 128.61% to ₹460.37 crore in the quarter ended June 2026.

Standalone numbers also swing to profit

Alongside consolidated performance, Kanoria Chemicals reported standalone net profit of ₹26.37 crore in Q1FY27, compared with a standalone net loss of ₹4.67 crore in Q1FY26. Standalone revenue was reported at ₹429.99 crore for the quarter. The company’s communication highlighted both consolidated and standalone performance, with both sets of numbers showing a reversal from losses in the year-ago period.

The Q1FY27 results were positioned as a clear improvement in reported earnings and operating performance compared with Q1FY26. The published consolidated table also provided EBITDA and EPS, offering a compact view of the quarter’s progress.

Key Q1FY27 consolidated metrics (as reported)

Board approval date and reporting timeline

The Board of Directors approved the unaudited standalone and consolidated financial results on August 11, 2026. The quarter covered the three months ended June 30, 2026. The company also disclosed a trading window closure for designated persons starting July 1, 2026, to remain closed until the declaration of the Q1FY27 financial results and for two additional days thereafter.

These timeline disclosures matter for investors tracking corporate governance and compliance practices, especially around periods when financial results are pending.

Stock price movement around the update

Kanoria Chemicals & Industries’ share price was reported down 0.92% from its previous close of ₹151.07, with the stock last traded at ₹149.69. Another update stated that as of August 7, 2026 (03:59 PM IST), the share price was ₹149.69, down 0.92% versus the previous closing price of ₹149.52.

These price points provide context on how the stock was trading around the time the market was digesting company updates and scheduled disclosures.

FY26 context: profitability returns, AGM scheduled

Beyond the quarterly performance, the company also disclosed that it returned to profitability in FY26. On a standalone basis, FY26 profit was reported at ₹34.41 crore (₹344.12 million), reversing a loss of ₹37.98 crore (₹379.80 million) in FY25. Standalone revenue from operations for FY26 was reported at ₹875.34 crore (₹8,753.44 million), while EBITDA was ₹81.58 crore (₹815.75 million).

For FY26 on a consolidated basis, profit was reported at ₹113.20 crore (₹11,320 lakh), reversing a net loss of ₹108.15 crore (₹10,815 lakh) in FY25. The turnaround was linked in the disclosure to a gain on loss of control of discontinued operations of ₹97.66 crore (₹9,766 lakh). Another FY26 note stated consolidated profit reached ₹113.20 crore (₹1,131.95 million), supported by a ₹80.81 crore (₹808.10 million) gain from discontinued operations related to APAG Holding AG.

The company scheduled its 66th Annual General Meeting (AGM) for September 2, 2026 at 11:00 A.M. to approve the audited financial statements for FY26.

Corporate actions and key dates at a glance

Why these numbers matter for investors

The Q1FY27 results show a large year-on-year swing, with reported revenue more than doubling and net profit turning positive. The consolidated EBITDA increase and the move from negative to positive EPS are additional indicators of the quarter’s improvement versus the year-ago period.

For longer-horizon context, FY26 disclosures highlight that the company had already returned to profitability for the full year, and that discontinued operations had a material role in consolidated earnings. Investors tracking the company may use the AGM agenda and audited FY26 financial statements as the next formal checkpoint.

Conclusion

Kanoria Chemicals’ Q1FY27 update reported a turnaround to ₹26.36 crore profit on ₹460.37 crore revenue, with the Board approving unaudited results on August 11, 2026. The next dated milestone on the calendar is the 66th AGM on September 2, 2026, where FY26 audited financials are set to be placed for shareholder approval.